Evidence map›Paper›PMID 40931232›Full record

ArticleImmunologic research2025

Multi-class machine learning-based classification of SCID-related genetic variants.

Ali Şahin, Gamze Sonmez, Mehmet Karaselek, İsmail Reisli

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Immunologic research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ali ŞahinDepartment of Emergency Medicine, Dr. Vefa Tanır Ilgın State Hospital, Konya, 42600, Türkiye.ORCID 0000-0002-3139-8205
Gamze SonmezFaculty of Medicine, Hacettepe University, Ankara, 06100, Türkiye.ORCID 0009-0001-3488-0283
Mehmet KaraselekDepartment of Immunology and Allergy, Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.ORCID 0000-0003-3201-8945
İsmail ReisliDepartment of Immunology and Allergy, Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye. ireisli@erbakan.edu.tr.ORCID 0000-0001-8247-6405

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVariants of uncertain significance (VUS) represent a major diagnostic challenge in the interpretation of genetic testing results, particularly in the context of inborn errors of immunity such as severe combined immunodeficiency (SCID). The inconsistency among computational prediction tools often necessitates expensive and time-consuming wet-lab analyses.

objectiveThis study aimed to develop disease-specific, multi-class machine learning models using in silico scores to classify SCID-associated genetic variants and improve the interpretation of VUS.

methodsGenes associated with SCID were identified based on the 2024 update of the International Union of Immunological Societies. Missense variants were retrieved from ClinVar and labeled as benign, likely benign, likely pathogenic, or pathogenic. Variants classified as VUS or with conflicting interpretations were excluded. In silico functional prediction scores were collected for each variant. Multi-class classification models were developed using six machine learning algorithms: Random Forest, XGBoost, Gradient Boosting, AdaBoost, Support Vector Machine and Logistic Regression. Performance was evaluated using five-fold cross-validation with five repeats (25 folds).

resultsA total of 537 variants from 71 genes were included in the final dataset. Among the models, Random Forest achieved the best performance with an accuracy of 0.70 ± 0.03 and the highest area under the receiver operating characteristic curve (AUROC: 0.90 ± 0.01). MetaRNN, BayesDel_addAF, and REVEL were the most predictive features.

conclusionThis study demonstrates that disease-specific, multi-class machine learning models leveraging in silico scores can effectively support the classification of SCID-related variants, offering a promising tool for improving VUS interpretation. KEY MESSAGES: Multi-class machine learning models can enhance the interpretation of SCID-related VUS. Random Forest showed the highest diagnostic accuracy and robustness among tested models. Disease-specific modeling improves classification performance despite limited datasets. Capsule Summary This study developed disease-specific multi-class machine learning models to classify SCID-related variants using in silico scores, with Random Forest showing the strongest performance in predicting variant pathogenicity.

Indexed as

Genetic VariationMachine LearningSevere Combined ImmunodeficiencyComputational BiologyComputer SimulationGenetic Predisposition to DiseaseGenetic TestingHumansInborn Errors of ImmunityMachine LearningSevere Combined ImmunodeficiencyVariant Classification

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.